From Sickle Cell to Stroke Prevention: Robert J. Adams’ Leadership in Brain Health Equity
Transforming Neurological Care Delivery: Barbara Vickrey’s SEQUINS Hall of Fame Journey
FDA Approves STS101 Nasal Powder as New Treatment for Acute Migraine
Breaking Barriers in Stroke Care: Insights From SEQUINS Hall of Famer Lewis B. Morgenstern, MD